Open AccessEfficacy and safety of tofacitinib in the treatment of ulcerative colitis: real-life experience in Andalusia
Author(s) -
Álvaro Hernández Martínez,
Pilar Navajas Hernández,
María del Mar Martín Rodríguez,
Marta Lázaro Saéz,
Raúl Vicente Olmedo Martín,
Andrea Núñez Ortiz,
Federico Argüelles Arias,
María del Carmen Fernández Cano,
Fernando Sánchez Sánchez,
Sandra Marín Pedrosa,
Javier González García,
Juan María Vázquez Morón
Publication year - 2022
Publication title -
revista española de enfermedades digestivas/revista española de enfermedades digestivas
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.331
H-Index - 38
eISSN - 2340-4167
pISSN - 1130-0108
DOI - 10.17235/reed.2022.8380/2021
Subject(s) - medicine , tofacitinib , discontinuation , ulcerative colitis , janus kinase inhibitor , adverse effect , refractory (planetary science) , retrospective cohort study , surgery , gastroenterology , rheumatoid arthritis , disease , physics , astrobiology